Integra LifeSciences Holdings CorporationIART
Key ratios
Operating cash flow growth
20.4%TTM
2025
-61.1%2024
-7.6%2023
-47.1%
EPS growth
-61.1%2023
FCF / Sales
1.6%TTM
2025
-1.9%2024
1.6%2023
4.7%
Net margin
-0.4%TTM
2025
-31.6%2024
-0.4%2023
4.4%
ROA
2.8%TTM
2025
2.4%2024
2.9%2023
1.8%
ROE
-0.7%TTM
2025
-39.9%2024
-0.4%2023
4.0%
Revenue growth
1.6%TTM
2025
1.5%2024
4.5%2023
-1.0%
Track IART in your journal
Save it to a watchlist, run a reverse DCF, and keep your notes on the company in one place. Free to start.
Figures are sourced from third parties and shown for research only. They may be delayed or incomplete, and nothing on this page is investment advice or a recommendation to buy or sell. Read the full disclaimer